लोड हो रहा है...

Outcomes of pulmonary vasodilator use in Veterans with pulmonary hypertension associated with left heart disease and lung disease

Randomized trials of pulmonary vasodilators in pulmonary hypertension due to left heart disease (Group 2) and lung disease (Group 3) have demonstrated potential for harm. Yet these therapies are commonly used in practice. Little is known of the effects of treatment outside of clinical trials. We aim...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Pulm Circ
मुख्य लेखकों: Gillmeyer, Kari R., Miller, Donald R., Glickman, Mark E., Qian, Shirley X., Klings, Elizabeth S., Maron, Bradley A., Hanlon, Joseph T., Rinne, Seppo T., Wiener, Renda S.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: SAGE Publications 2021
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC8020250/
https://ncbi.nlm.nih.gov/pubmed/33868640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/20458940211001714
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!